INTRODUCTION
Chronic kidney disease (CKD) is an important public health problem and its prevalence is increasing worldwide (1) . The incidence and prevalence of renal replacement therapy (RRT) for patients with end-stage renal disease (ESRD) in Turkey have increased during the past decades (2, 3) .
The increase in the number of ESRD cases over the years may be considered
MATERIAL and METHODS
The project covers private hemodialysis centers. According to 2011 data, there are 871 centers that provide hemodialysis services in Turkey. Among these centers, 44% of them are privately-owned providing healthcare services to 70% of the patients. The study focuses around a total of 296 centers with patients between 51 and 150, and the total number of patients treated in these centers is 26,659. Table II shows the distribution of centers based on the number of patients. Hemodialysis centers with patients less than 50 or more than 150 were excluded from the study due to the fact that they might have affected the average cost. Because the data of the centers to be analyzed had to be exact in order for the study to achieve its objective, cost analysis was conducted on 70 hemodialysis centers audited independently by international audit companies. Table III shows the number of patients and treatments in the centers that are part of this study. This study is based on the previously conducted cost analysis study with the objective of calculating the unit costs per treatment in the private hemodialysis centers operating in Turkey, using the 2009 and 2010 data (9, 10) . In this study, the data of the year 2011 have been added to the previous study.
Being informed about the cost of healthcare services is one of the prerequisites of determining evidence-based healthcare policies. The important point to be emphasized here is that cost data are country-specifi c and cost calculations valid for one country may not be applicable in another country. Input costs and treatment methods applied are the two main reasons which may vary from one country to another. In this study, a cost system has been established to determine the unit cost per treatment of hemodialysis specifi c to Turkey and a cost table has been created to perform cost calculations.
Establishing a Costing System
In the costing system, only the production costs are charged to the costs of the produced services; on the other hand period expenses are refl ected directly on the profi t and loss statements. Production of service expenses are made up of fi xed and variable costs. Variable production costs are costs that change in line with production volume and that do not arise when there is no production. Direct raw material and supplies, most of direct labor and some general production expenses such as power consumption, equipment spare parts are such costs. Fixed production costs are costs that are not affected by the production volume; in other words they are costs, the total of which would remain the same regardless of changes in production quantities. Many items of the general production costs (i.e. depreciation, lease, property and vehicle taxes and insurance premiums, wages of technical staff, etc.) and sometimes direct labor costs years. Incidence fi gures have been reported as 144 per million  population in 1998, 188 in 2008, 197 in 2009, and 264 in 2010, respectively (4, 5) . This rising trend is expected to continue in the coming years, particularly due to the aging of the population and the increase in the occurrence of diabetes which is one of the most important underlying causes of ESRD.
An important majority of the ESRD patients in Turkey are treated by hemodialysis, particularly due to the problems faced in organ transplantation. The fact that hemodialysis treatment in Turkey is mainly conducted in hemodialysis centers has resulted in an increase in the number of both public and privately owned centers (6,7) ( Table I ). As shown in Table I , hemodialysis treatment is provided predominantly by the private sector. The analysis of the period between 1996 and 2011 shows that the ratio of the patients treated in the Ministry of Health institutions to the total number of hemodialysis patients has dropped from 71% in 1996 to 30% in 2011, while the ratio of the patients treated in the private sector has gone up from 29% in 1996 to 70% in 2011 ( Table I ).
Considering that hemodialysis treatment is predominantly fi nanced by public funds, it is possible to say that the sectoral division between the service provider and the service operator is remarkable for this type of treatment compared to other types of treatments. The increase in the number of treated patients and hemodialysis machines has naturally led to an increase in the spending for this type of treatment. Hemodialysis expenditures in Turkey are covered by the public and the Social Security Institution (SSI) is the major fi nancier of the services. Social Security Institution determines the principles of hemodialysis treatment as well as methods and amounts of reimbursement. These are published through Health Implementation Communiqué (HIC) annually or revised from time to time during implementation. In 2011, as in 2010, HIC set forth the reimbursement price for hemodialysis treatment as 145 TL per treatment.
As explained above, demand for hemodialysis treatment continues to increase every year and this increase in demand is mainly met by the private sector centers. As such, private sector is a very important and key partner in provision of these services. The real cost of these services have long been discussed in different spheres of the health care system. The private sector complains that the reimbursement price set by the SSI is not in line with the real cost of these services to the dialysis centers and asks for an increase in order to survive and sustain the quality of the services provided to the patients. The SSI, on the other hand, consistent with the cost containment approaches adopted in recent years in almost all segments of the health care system, have not responded positively to this demand so far. Costing studies in the Turkish health care system is rare and considering the evidence based policy making approaches and the need to justify the reimbursement price increases as mentioned above, their possible contribution to the health care system is In this study, initially a cost table was created in Microsoft Excel program. The fi rst column of this table included expense types, account codes and names while the fi rst line included the hemodialysis centers (expense locations) that were part of the study. Cost account groups of 7/A alternative mentioned above were used while determining the expense types. Salaries and expenses of personnel (civil servants) classifi ed in the third group were not included since such personnel are not employed by the private companies. Subgroups of expense types were created under the account groups. The expenses of the hemodialysis centers were taken from the yearend trial balance and entered into the Microsoft Access Program; then they were matched with the groups according to expense types and their totals were transferred to the Excel cost table. Total expenses and the amounts of these expenses based on their types are among fi xed production costs. No matter which method is applied, variable production costs are defi nitely charged to the cost of the service produced. The way that the fi xed production costs are charged may vary depending on the preferred method (11).
The costing system in this study has been established using full costing method based on the scope of the cost, actual costing method based on the timing of the cost, and process costing method based on the way the cost is determined (type of service production).
There are three methods of scope-based costing: full costing, variable costing, and normal costing. In the full costing method, all production costs both variable and fi xed incurred in a specifi c period are charged to the production performed in that period. In short, all the service production costs of a period are charged in full to the service unit.
Service costs can be determined before or after production. There are three methods of costing, namely actual, estimated and standard costing that indicate the time of costing. Actual costing method has been used in this study. In actual costing method, actual costs incurred after production are taken into account. This method is also known as historical costing or backdated costing.
Charging the expenses to the manufactured products requires different approaches under different production conditions. These approaches can be explained with two methods which are order cost system and process costing. In this study, process costing has been used. Assuming that the whole service product utilizes the input equally, the method involves calculating unit service cost by dividing total cost by the produced service units.
Creating the Cost Chart
All enterprises in Turkey that keep accounting records on a balance sheet basis are required to comply with the "General 
Data Sources
Data required for the study were obtained from the following sources:
• Statistical records of the hemodialysis centers (Number of patients, treatments, staff, machines)
were calculated. Total expenses of each individual hemodialysis center was divided by the produced service units to arrive at unit cost. Financial records of some of the dialysis centers (DC65-66) in this study are kept in consolidated form. Since the expenses of these centers cannot be broken down, they were entered directly into the cost table. • Balance sheet (2011 fi scal period)
• Profi t and loss statement (2011 fi scal period)
• Accounting of the hemodialysis centers -2011 yearend trial balance (detailed) 
RESULTS
Number of patients, treatments, staff, machines as well as number of treatments per patient, staff and machines in the hemodialysis centers are shown in Table IV . As seen in the table, average weekly number of treatments per patient is 2.84.
Analyses on expense and revenue types in the centers that are part of the study are shown in Table V . Wages and expenses of workers with a share of 33.2%, followed by direct raw materials and supplies with a share of 28.1% stand out as the two major cost groups in the total expenses. Wages and expenses of workers include the wages paid to all employees, social security premiums, social benefi ts and similar expenses. Healthcare services are labor-intensive services; therefore the share of wages and expenses of workers to be higher than the other cost groups is an expected result. Direct raw materials and supplies include various expenses like stationery, medical supplies, medications, fuel and food. Externally obtained utilities and services include electricity, communication, transportation, maintenance and cleaning services. Expenses like insurance premiums, advertising and marketing expenses, various accommodation and travel allowances are grouped under miscellaneous expenses.
Results of the analyses based on these expense types are shown in detail in Table VI . As may be observed in the table, the highest share in the direct raw materials and expenses group belongs to medical and laboratory supplies subgroup with 81.4% while basic wages make up the highest share with 74.3% in the wages and expenses of workers group. The major expense subgroup in the externally obtained utilities and services expense type is externally obtained medical services expenses with 32.0%. Lease expenses have the highest share in the miscellaneous expenses group with 67.2%. Direct raw materials and supplies expenses as well as external utilities and services obtained expenses have shown an increase in 2011. The share of direct raw materials and supplies in total expenses ranged between 18.8% and 37.8%, while the general average share of this expense group is 28.1%. Taking into account that the highest share in this group belongs to medical and laboratory supplies, it would be accurate to state that the hemodialysis centers procure these supplies at different prices depending on their buying and negotiation power. The analysis of another expense type, wages and expenses of workers in view of its share in the total expenses shows that it ranged from 21.8% to 48.6%, while the average share of this expense group in total expenses is 33.2%. The third most important group in the expense types is externally obtained utilities and services with a general average share of 19.6% in the total expenses, ranging between 7.6% and 31.9%. The important point that needs to be reiterated is that the expense types as well as their distribution will vary due to specifi c conditions and different healthcare systems in each country. Assuming that labor, supplies, leases, electricity, water and similar utilities cost the same in all the countries and their share to be equal, and using the cost of services in another country as basis to determine the prices of the same services in Analysis results of the studied centers' average unit costs per patient, machine and treatment are provided in Table VIII in  comparison to 2009 and 2010 results. In this study, unit cost per patient has been found as 24,160.6 TL, unit cost per machine as 89,796 TL and unit cost per treatment as 163.5 TL, respectively. Unit cost per treatment displays a rising trend over the years. The reason for the decline of unit treatment cost in 2011 compared to 2010 can be explained by the increase in the number of treatments and to a lesser extent by the decrease in personnel the country would not be an accurate and scientifi c approach. A very simple example for this would be the fact that while prices of the solutions and medications used in treatment are determined according to free market conditions in some countries, they are regulated by the governments in many others. In this case, the share of medications in the total expenses would cost very differently in one country compared to another. On a similar note, expenses like wages paid for labor and social security premiums should be determined and calculated according to each country's specifi c conditions.
The results of the unit cost analyses obtained in the study are presented in Table VII . The table shows the studied centers' vide information about the costs to be borne, particularly while planning procurement of new hemodialysis machines. The most important type of cost in terms of this study is unit cost per treatment. According to Health Implementation Communiqué, reimbursement amount in 2011 which is also the year that provided the data for this study was 145 TL per treatment. A comparative graph of hemodialysis centers' unit costs per treatment, unit price per treatment reimbursed by SSI and the average unit cost found in this study is shown in Figure 1 .
As explained in the scope of the study, hemodialysis centers have been grouped according to the number of patients and only the centers that treat 51-79, 80-100, and 101-150 patients have been included in this study. Table IX shows average costs per treatment in these groups of centers. As the table indicates, average unit cost per treatment is higher in the hemodialysis center groups with the lowest and the highest number of patients compared to the other group.
DISCUSSION
The objective of this study is to determine the cost per treatment in private hemodialysis centers. Hemodialysis centers with 51-150 patients were divided into three groups as part of the study and of the 296 centers that met this criterion, the data of 70 centers whose fi nancial data were accessible have been analyzed. This study is based on the 2009 and 2010 cost analysis study, and conducted by adding the data of 2011.
expenses. Unit cost per patient is an important data especially in terms of developing ESRD-related healthcare policies. Multiplying the existing number of ESRD patients and the number of potential future ESRD patients by this fi gure would provide insight to the share of hemodialysis treatment in the healthcare expenditure. Unit cost per machine, on the other hand, may pro- The present study showed that the average unit cost per treatment is high for centers with low number of patients because of constant expenses. However, unit cost also increases after a certain number of patients (more than 100 in our study) because of the increased expenses, such as increased wages due to increased numbers of personnel and increased expenses of patient transportation.
At the conclusion of the study, average cost per treatment in the centers that took part in the study was found to be 163.5 TL. This fi gure is higher than the unit price per treatment reimbursed by SSI; as such it is an indication that the centers' earnings are less than their actual costs. The reimbursement of dialysis in Turkey is signifi cantly lower than many other countries. In a study by Vanholder et al. (12) The fact that hemodialysis centers are earning less than their actual costs in Turkey may in time lead to a compromise from patient service quality and later result in closing down. A total of 33 privately owned hemodialysis centers have closed down in the last two years while only 8 new ones have been opened. Due to the fact that they are earning less than their costs, private hemodialysis centers choose a number of methods like merging depending on location and physical availability, fi nancing by bank loans, delaying loan payments and freezing doctors' and personnel wages in order to continue providing services. Considering that the main service provider of hemodialysis treatment is the private sector, the decrease in the number of dialysis centers may cause serious problems in terms of patients' access to services.
As emphasized in this manuscript, private sector is an indispensible partner in hemodialysis treatment and plays an important role in providing these services. On the other hand, as a result of the latest health reforms, SSI has acquired a monopsonic power and become the sole buyer of healthcare services in Turkey. Under these circumstances, SSI as the buyer of the services in hemodialysis treatment and private hemodialysis centers as the predominant provider of these services are meeting the requirements and needs of ESRD patients with different interests. Thus, it would be essential for both SSI and private HD centers to determine a unit treatment price based on the service costs of these centers. The unit cost per treatment found in this study is higher than the unit price
